E2609 for Mild Cognitive Impairment Due to Alzheimer's Disease
Language
Undefined
Purpose: To evaluate the safety and efficacy of the experimental drug E2609 in people with mild cognitive impairment or mild dementia due to Alzheimer's disease.
Source: Alzheimers Clinical Trials - Category: Geriatrics Authors: chirschman Source Type: clinical trials